世界の慢性閉塞性肺疾患（COPD）治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4015
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、慢性閉塞性肺疾患（COPD）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、ホスホジエステラーゼ4型阻害剤、気管支拡張剤、その他）、用途別市場規模（病院、診療所、小売薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・慢性閉塞性肺疾患（COPD）治療の市場動向
・企業の競争状況、市場シェア
・慢性閉塞性肺疾患（COPD）治療の種類別市場規模と予測2016-2027（コルチコステロイド、ホスホジエステラーゼ4型阻害剤、気管支拡張剤、その他）
・慢性閉塞性肺疾患（COPD）治療の用途別市場規模と予測2016-2027（病院、診療所、小売薬局、その他）
・慢性閉塞性肺疾患（COPD）治療の北米市場規模2016-2027（アメリカ、カナダ）
・慢性閉塞性肺疾患（COPD）治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・慢性閉塞性肺疾患（COPD）治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・慢性閉塞性肺疾患（COPD）治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・慢性閉塞性肺疾患（COPD）治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（AstraZeneca、Boehringer Ingelheim International GmbH、GlaxoSmithKline、Novartis AG、Teva Pharmaceutical Industries、Sunovion Pharmaceuticals、CHIESI Farmaceutici、Orion Corporation、Mylan）
・結論

Market Analysis and Insights: Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market
The global Chronic Obstructive Pulmonary Disease (COPD) Treatment market size is projected to reach US$ 16110 million by 2027, from US$ 12890 million in 2020, at a CAGR of 2.8% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Chronic Obstructive Pulmonary Disease (COPD) Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Chronic Obstructive Pulmonary Disease (COPD) Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Chronic Obstructive Pulmonary Disease (COPD) Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Chronic Obstructive Pulmonary Disease (COPD) Treatment market.

Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Scope and Market Size
Chronic Obstructive Pulmonary Disease (COPD) Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Obstructive Pulmonary Disease (COPD) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Corticosteroids
Phosphodiesterase Type 4 Inhibitors
Bronchodilators
Others

Segment by Application
Hospital
Clinic
Retail Pharmacies
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca
Boehringer Ingelheim International GmbH
GlaxoSmithKline
Novartis AG
Teva Pharmaceutical Industries
Sunovion Pharmaceuticals
CHIESI Farmaceutici
Orion Corporation
Mylan

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Corticosteroids
1.2.3 Phosphodiesterase Type 4 Inhibitors
1.2.4 Bronchodilators
1.2.5 Others
1.3 Market by Application
1.3.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Retail Pharmacies
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Perspective (2016-2027)
2.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Growth Trends by Regions
2.2.1 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Industry Dynamic
2.3.1 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Trends
2.3.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Drivers
2.3.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Challenges
2.3.4 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Chronic Obstructive Pulmonary Disease (COPD) Treatment Players by Revenue
3.1.1 Global Top Chronic Obstructive Pulmonary Disease (COPD) Treatment Players by Revenue (2016-2021)
3.1.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue
3.4 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Concentration Ratio
3.4.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue in 2020
3.5 Chronic Obstructive Pulmonary Disease (COPD) Treatment Key Players Head office and Area Served
3.6 Key Players Chronic Obstructive Pulmonary Disease (COPD) Treatment Product Solution and Service
3.7 Date of Enter into Chronic Obstructive Pulmonary Disease (COPD) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Chronic Obstructive Pulmonary Disease (COPD) Treatment Breakdown Data by Type
4.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Historic Market Size by Type (2016-2021)
4.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecasted Market Size by Type (2022-2027)

5 Chronic Obstructive Pulmonary Disease (COPD) Treatment Breakdown Data by Application
5.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Historic Market Size by Application (2016-2021)
5.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2016-2027)
6.2 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
6.2.1 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2016-2021)
6.2.2 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2022-2027)
6.2.3 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2016-2027)
6.3 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application
6.3.1 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2016-2021)
6.3.2 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2022-2027)
6.3.3 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2016-2027)
6.4 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country
6.4.1 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2016-2021)
6.4.2 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2016-2027)
7.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
7.2.1 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2016-2021)
7.2.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2022-2027)
7.2.3 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2016-2027)
7.3 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application
7.3.1 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2016-2021)
7.3.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2022-2027)
7.3.3 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2016-2027)
7.4 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country
7.4.1 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2016-2021)
7.4.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2016-2027)
8.2 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
8.2.1 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application
8.3.1 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region
8.4.1 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2016-2027)
9.2 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
9.2.1 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2016-2027)
9.3 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application
9.3.1 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2016-2027)
9.4 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country
9.4.1 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2016-2027)
10.2 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
10.2.1 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application
10.3.1 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country
10.4.1 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
11.1.4 AstraZeneca Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 Boehringer Ingelheim International GmbH
11.2.1 Boehringer Ingelheim International GmbH Company Details
11.2.2 Boehringer Ingelheim International GmbH Business Overview
11.2.3 Boehringer Ingelheim International GmbH Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
11.2.4 Boehringer Ingelheim International GmbH Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
11.2.5 Boehringer Ingelheim International GmbH Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
11.3.4 GlaxoSmithKline Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
11.4.4 Novartis AG Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
11.4.5 Novartis AG Recent Development
11.5 Teva Pharmaceutical Industries
11.5.1 Teva Pharmaceutical Industries Company Details
11.5.2 Teva Pharmaceutical Industries Business Overview
11.5.3 Teva Pharmaceutical Industries Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
11.5.4 Teva Pharmaceutical Industries Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
11.5.5 Teva Pharmaceutical Industries Recent Development
11.6 Sunovion Pharmaceuticals
11.6.1 Sunovion Pharmaceuticals Company Details
11.6.2 Sunovion Pharmaceuticals Business Overview
11.6.3 Sunovion Pharmaceuticals Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
11.6.4 Sunovion Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
11.6.5 Sunovion Pharmaceuticals Recent Development
11.7 CHIESI Farmaceutici
11.7.1 CHIESI Farmaceutici Company Details
11.7.2 CHIESI Farmaceutici Business Overview
11.7.3 CHIESI Farmaceutici Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
11.7.4 CHIESI Farmaceutici Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
11.7.5 CHIESI Farmaceutici Recent Development
11.8 Orion Corporation
11.8.1 Orion Corporation Company Details
11.8.2 Orion Corporation Business Overview
11.8.3 Orion Corporation Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
11.8.4 Orion Corporation Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
11.8.5 Orion Corporation Recent Development
11.9 Mylan
11.9.1 Mylan Company Details
11.9.2 Mylan Business Overview
11.9.3 Mylan Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
11.9.4 Mylan Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
11.9.5 Mylan Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Corticosteroids
Table 3. Key Players of Phosphodiesterase Type 4 Inhibitors
Table 4. Key Players of Bronchodilators
Table 5. Key Players of Others
Table 6. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Regions (2016-2021)
Table 10. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Regions (2022-2027)
Table 12. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Trends
Table 13. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Drivers
Table 14. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Challenges
Table 15. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Restraints
Table 16. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Players (2016-2021)
Table 18. Global Top Chronic Obstructive Pulmonary Disease (COPD) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment as of 2020)
Table 19. Ranking of Global Top Chronic Obstructive Pulmonary Disease (COPD) Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Chronic Obstructive Pulmonary Disease (COPD) Treatment Product Solution and Service
Table 23. Date of Enter into Chronic Obstructive Pulmonary Disease (COPD) Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. AstraZeneca Company Details
Table 64. AstraZeneca Business Overview
Table 65. AstraZeneca Chronic Obstructive Pulmonary Disease (COPD) Treatment Product
Table 66. AstraZeneca Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021) & (US$ Million)
Table 67. AstraZeneca Recent Development
Table 68. Boehringer Ingelheim International GmbH Company Details
Table 69. Boehringer Ingelheim International GmbH Business Overview
Table 70. Boehringer Ingelheim International GmbH Chronic Obstructive Pulmonary Disease (COPD) Treatment Product
Table 71. Boehringer Ingelheim International GmbH Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021) & (US$ Million)
Table 72. Boehringer Ingelheim International GmbH Recent Development
Table 73. GlaxoSmithKline Company Details
Table 74. GlaxoSmithKline Business Overview
Table 75. GlaxoSmithKline Chronic Obstructive Pulmonary Disease (COPD) Treatment Product
Table 76. GlaxoSmithKline Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021) & (US$ Million)
Table 77. GlaxoSmithKline Recent Development
Table 78. Novartis AG Company Details
Table 79. Novartis AG Business Overview
Table 80. Novartis AG Chronic Obstructive Pulmonary Disease (COPD) Treatment Product
Table 81. Novartis AG Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021) & (US$ Million)
Table 82. Novartis AG Recent Development
Table 83. Teva Pharmaceutical Industries Company Details
Table 84. Teva Pharmaceutical Industries Business Overview
Table 85. Teva Pharmaceutical Industries Chronic Obstructive Pulmonary Disease (COPD) Treatment Product
Table 86. Teva Pharmaceutical Industries Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021) & (US$ Million)
Table 87. Teva Pharmaceutical Industries Recent Development
Table 88. Sunovion Pharmaceuticals Company Details
Table 89. Sunovion Pharmaceuticals Business Overview
Table 90. Sunovion Pharmaceuticals Chronic Obstructive Pulmonary Disease (COPD) Treatment Product
Table 91. Sunovion Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021) & (US$ Million)
Table 92. Sunovion Pharmaceuticals Recent Development
Table 93. CHIESI Farmaceutici Company Details
Table 94. CHIESI Farmaceutici Business Overview
Table 95. CHIESI Farmaceutici Chronic Obstructive Pulmonary Disease (COPD) Treatment Product
Table 96. CHIESI Farmaceutici Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021) & (US$ Million)
Table 97. CHIESI Farmaceutici Recent Development
Table 98. Orion Corporation Company Details
Table 99. Orion Corporation Business Overview
Table 100. Orion Corporation Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021) & (US$ Million)
Table 101. Orion Corporation Recent Development
Table 102. Mylan Company Details
Table 103. Mylan Business Overview
Table 104. Mylan Chronic Obstructive Pulmonary Disease (COPD) Treatment Product
Table 105. Mylan Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021) & (US$ Million)
Table 106. Mylan Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Type: 2020 VS 2027
Figure 2. Corticosteroids Features
Figure 3. Phosphodiesterase Type 4 Inhibitors Features
Figure 4. Bronchodilators Features
Figure 5. Others Features
Figure 6. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Other Case Studies
Figure 11. Chronic Obstructive Pulmonary Disease (COPD) Treatment Report Years Considered
Figure 12. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Regions (2022-2027)
Figure 16. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Players in 2020
Figure 17. Global Top Chronic Obstructive Pulmonary Disease (COPD) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue in 2020
Figure 19. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Type (2016-2027)
Figure 23. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application (2016-2027)
Figure 24. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Country (2016-2027)
Figure 25. United States Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Type (2016-2027)
Figure 29. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application (2016-2027)
Figure 30. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Country (2016-2027)
Figure 31. Germany Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Region (2016-2027)
Figure 41. China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. AstraZeneca Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
Figure 61. Boehringer Ingelheim International GmbH Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
Figure 62. GlaxoSmithKline Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
Figure 63. Novartis AG Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
Figure 64. Teva Pharmaceutical Industries Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
Figure 65. Sunovion Pharmaceuticals Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
Figure 66. CHIESI Farmaceutici Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
Figure 67. Orion Corporation Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
Figure 68. Mylan Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

以下、関連資料のご紹介

世界の慢性難治性咳（CRC）治療市場規模・現状・予測（2021年-2027年）

Global Chronic Refractory Cough (CRC) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5661 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、慢性難治性咳（CRC）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（言語療法、理学療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界の慢性リンパ性白血病（CLL）治療市場規模・現状・予測（2021年-2027年）

Global Chronic Lymphocytic Leukemia (CLL) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4011 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、慢性リンパ性白血病（CLL）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（CLL初期治療、CLL二次治療）、用途別市場規模（大人用、子供用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界の肺・気道疾患治療市場規模・現状・予測（2021年-2027年）

Global Lung Pulmonary Airway Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4446 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、肺・気道疾患治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（気管支拡張薬、細胞毒性薬、抗生物質、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界の慢性骨髄性白血病（CML）治療市場規模・現状・予測（2021年-2027年）

Global Chronic Myeloid Leukemia (CML) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4014 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、慢性骨髄性白血病（CML）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（標的療法、化学療法、放射線療法、脾臓摘出術、幹細胞移植）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米...

世界の顧みられない熱帯病（NTD）治療市場規模・現状・予測（2021年-2027年）

Global Neglected Tropical Disease (NTD) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4558 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、顧みられない熱帯病（NTD）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、ワクチン）、用途別市場規模（病院・クリニック、診断センター、学術・研究機関）、主要地域別市場規模（北米、アメリカ...

世界のドライアイ診断＆治療市場規模・現状・予測（2021年-2027年）

Global Dry Eye Disease Diagnostics and Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4161 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、ドライアイ診断＆治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（蒸発性ドライアイ症候群、水性ドライアイ症候群）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメ...

世界の慢性片頭痛治療市場規模・現状・予測（2021年-2027年）

Global Chronic Migraine Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4013 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、慢性片頭痛治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、代替治療）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、...

世界の後期慢性腎臓病治療薬市場規模・現状・予測（2021年-2027年）

Global Late Stage Chronic Kidney Disease Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4413 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、後期慢性腎臓病治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カルシウム受容体刺激薬、ビタミンDステロール、カリウムバインダー、その他）、用途別市場規模（病院薬局、オンライン薬局、小売薬局）、主...

世界の慢性歯肉口内炎治療市場規模・現状・予測（2021年-2027年）

Global Chronic Gingivostomatitis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5660 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、慢性歯肉口内炎治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非ステロイド性抗炎症薬、抗ウイルス薬、抗菌薬、その他）、用途別市場規模（病院＆診療所、大学＆研究機関、その他）、主要地域別市場規模（北...

世界の顕微鏡的多発血管炎（MPA）治療市場規模・現状・予測（2021年-2027年）

Global Microscopic Polyangiitis(MPA) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4506 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、顕微鏡的多発血管炎（MPA）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アバコパン、免疫グロブリン、リツキシマブバイオシミラー、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別...

世界の肺・気道疾患治療市場規模・現状・予測（2021年-2027年） Lung (Pulmonary) Airway Disease include bronchiectasis, asthma and COPD.Disease narrow down or block the airways. Such breathing problems caused due to Lung (Pulmonary) Airway Disease may inhibit the body receiving sufficient oxygen. Market Analysis and Insights: Global Lung Pulmonary Airway Disease…
世界のCOPD治療薬市場規模・現状・予測（2021年-2027年） Chronic Obstructive Pulmonary Disease (COPD) is a progressive disorder associated with chronic inflammation of the airways and lungs. Persistent breathing difficulties and repeated exacerbations of COPD symptoms make the disease one of the leading causes of morbidity, and the fifth-leading cause of …
世界のCOPD用治療薬市場規模・現状・予測（2021年-2027年） Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. Symptoms include breathing difficulty, cough, mucus (sputum) production and wheezing. It's typically caused by long-term exposure to irritating gases or particulate matt…
世界の抗喘息薬＆COPD薬市場規模・現状・予測（2021年-2027年） The anti-asthmatics and chronic obstructive pulmonary disease (COPD) market consists of sales of anti-asthmatics and chronic obstructive pulmonary disease (COPD) drugs which are used to relieve the frequency of acute attacks of asthma, emphysema, chronic bronchitis, and nocturnal awakenings. The cla…
世界の喘息/COPD併用薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Asthma/COPD Combination Medication Market The global Asthma/COPD Combination Medication market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high …